High-dose glucocorticoids improve renal failure reversibility in patients with newly diagnosed multiple myeloma

Journal article

Peer reviewed

Ulas DARDA BAYRAKTAR, Sean WARSCH and Denise PEREIRA

American journal of hematology, Vol.86(2), pp.224-227

2011

PMID: 21264915

Abstract

Hematologic and hematopoietic diseases

Nephropathies. Renovascular diseases. Renal failure

Renal failure

Nephrology. Urinary tract diseases

Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis

Biological and medical sciences

Medical sciences

16 Record Views

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Citation topics: 1 Clinical & Life Sciences; 1.130 Lymphomas; 1.130.617 Multiple Myeloma
Web Of Science research areas: Hematology
ESI research areas: Clinical Medicine

This output has contributed to the advancement of the following goals:

Source: InCites

Title: High-dose glucocorticoids improve renal failure reversibility in patients with newly diagnosed multiple myeloma
Creators: Ulas DARDA BAYRAKTAR - Division of Hematology/Oncology, Department of Medicine, University of Miami Miller School of Medicine, Miami, Florida, United States
Sean WARSCH - Division of Hematology/Oncology, Department of Medicine, University of Miami Miller School of Medicine, Miami, Florida, United States
Denise PEREIRA - Division of Hematology/Oncology, Department of Medicine, University of Miami Miller School of Medicine, Miami, Florida, United States
Publication Details: American journal of hematology, Vol.86(2), pp.224-227
Publisher: Wiley-Liss; Hoboken, NJ
Academic Unit: Miller School of Medicine; UMMG Dept of Medicine - Hematology/Oncology
Language: English
Resource Type: Journal article
PMID: 21264915
Record Identifier: 991031559305402976